Literature DB >> 27082696

The non-canonical functions of p27(Kip1) in normal and tumor biology.

Savitha S Sharma1, W Jackson Pledger1,2.   

Abstract

p27(Kip1) was first discovered as a key regulator of cell proliferation. The canonical function of p27(Kip1) is inhibition of cyclin-dependent kinase (CDK) activity. In addition to its initial identification as a CDK inhibitor, p27(Kip1) has also emerged as an intrinsically unstructured, multifunctional protein with numerous non-canonical, CDK-independent functions that exert influence on key processes such as cell cycle regulation, cytoskeletal dynamics and cellular plasticity, cell migration, and stem-cell proliferation and differentiation. Many of these non-canonical functions, depending on the cell-specific contexts such as oncogenic activation of signaling pathways, have the ability to turn pro-oncogenic in nature and even contribute to tumor-aggressiveness and metastasis. This review discusses the various non-canonical, CDK-independent mechanisms by which p27(Kip1) functions either as a tumor-suppressor or tumor-promoter.

Entities:  

Keywords:  cell cycle; cell migration; cyclin-dependent kinases; metastasis; non-canonical functions; p27Kip1; stem-cell biology

Mesh:

Substances:

Year:  2016        PMID: 27082696      PMCID: PMC4889241          DOI: 10.1080/15384101.2016.1157238

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  106 in total

1.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

4.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

5.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

6.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

7.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

8.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

9.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

Authors:  A Koff; M Ohtsuki; K Polyak; J M Roberts; J Massagué
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

10.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Authors:  M V Ponce-Castañeda; M H Lee; E Latres; K Polyak; L Lacombe; K Montgomery; S Mathew; K Krauter; J Sheinfeld; J Massague
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

View more
  27 in total

1.  Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.

Authors:  Guosong Jiang; Chao Huang; Jingxia Li; Haishan Huang; Jingjing Wang; Yawei Li; Fei Xie; Honglei Jin; Junlan Zhu; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

2.  SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.

Authors:  Karthik M Kodigepalli; Serena Bonifati; Nagaraja Tirumuru; Li Wu
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

3.  Haploinsufficient tumor suppressor genes.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Adv Med Biol       Date:  2017 1st Quarter

4.  Mapping Interactions between p27 and RhoA that Stimulate Cell Migration.

Authors:  Aaron H Phillips; Li Ou; Alexandre Gay; Arnaud Besson; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2018-02-01       Impact factor: 5.469

5.  p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy-lysosomal pathway and coordinate cell cycle and cell growth.

Authors:  Ada Nowosad; Pauline Jeannot; Caroline Callot; Justine Creff; Renaud Thierry Perchey; Carine Joffre; Patrice Codogno; Stephane Manenti; Arnaud Besson
Journal:  Nat Cell Biol       Date:  2020-08-17       Impact factor: 28.824

6.  Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways.

Authors:  Mei-Ling Chan; Chia-Chun Yu; Jui-Ling Hsu; Wohn-Jenn Leu; She-Hung Chan; Lih-Ching Hsu; Shih-Ping Liu; Polina M Ivantcova; Özdemir Dogan; Stefan Bräse; Konstantin V Kudryavtsev; Jih-Hwa Guh
Journal:  Oncotarget       Date:  2017-05-20

7.  FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia.

Authors:  Ines Peschel; Silvio R Podmirseg; Martin Taschler; Justus Duyster; Katharina S Götze; Heinz Sill; David Nachbaur; Heidelinde Jäkel; Ludger Hengst
Journal:  Haematologica       Date:  2017-05-18       Impact factor: 9.941

8.  Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.

Authors:  Stefania Berton; Martina Cusan; Ilenia Segatto; Francesca Citron; Sara D'Andrea; Sara Benevol; Michele Avanzo; Alessandra Dall'Acqua; Monica Schiappacassi; Robert G Bristow; Barbara Belletti; Gustavo Baldassarre
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

9.  NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors.

Authors:  Smitha Antony; Guojian Jiang; Yongzhong Wu; Jennifer L Meitzler; Hala R Makhlouf; Diana C Haines; Donna Butcher; Dave S Hoon; Jiuping Ji; Yiping Zhang; Agnes Juhasz; Jiamo Lu; Han Liu; Iris Dahan; Mariam Konate; Krishnendu K Roy; James H Doroshow
Journal:  Mol Carcinog       Date:  2017-08-30       Impact factor: 4.784

10.  p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

Authors:  Ilenia Pellizzari; Linda Fabris; Stefania Berton; Ilenia Segatto; Francesca Citron; Sara D'Andrea; Martina Cusan; Sara Benevol; Tiziana Perin; Samuele Massarut; Vincenzo Canzonieri; Monica Schiappacassi; Barbara Belletti; Gustavo Baldassarre
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.